Ledger.Open graph →

SEC Form D · Amendment · filed February 16, 2022

LexaGene Holdings Inc

Offering

$8.1M

Sold

$3.5M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

BEVERLY, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Jeffrey M. Mitchell · Beverly, MAExec Steven Armstrong · Beverly, MAExec John (Jack) F. Regan · Beverly, MAExec · Director Jane R. Sykes · Beverly, MADirector Joseph M. Caruso · Beverly, MADirector Thomas R. Slezak · Beverly, MADirector Stephen J. Mastrocola · Beverly, MADirector Patrick Townzen · TAMPA, FLExec Lee Fixel · New York, NYExec · Director Ron Lockhart · PAOLI, PAExec Matthew Stern · Los Angeles, CADirector Ronald Redell · TAMPA, FLDirector Benjamin Taft · Los Angeles, CADirector Gheorghe Rotar · TAMPA, FLDirector Gary Cohn · Cleveland, OHExec · Director Mark Froimson · Cleveland, OHExec Kevin D. Demeritt · Newport Beach, CADirector Luke V. Carlson · San Francisco, CADirector Kirk Wycoff · Brentwood, TNExec Sarah Biller · Brentwood, TNDirector John Philpott · Brentwood, TNDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗